1. Home
  2.  » 
  3. Catalent News
  4.  » Catalent Receives RoSPA Silver Award for its Health and Safety Practices

Catalent Receives RoSPA Silver Award for its Health and Safety Practices

SOMERSET, N.J. – April 8, 2020 — Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it has been recognized by the Royal Society for the Prevention of Accidents (RoSPA) for its health and safety practices, achieving a silver award for a second consecutive year.

The RoSPA Awards scheme, which is the longest-running industry awards scheme in the U.K., recognizes achievement in health and safety management systems, including practices such as leadership and workforce involvement.

Julia Small, Head of Qualifications, Awards and Events, RoSPA said, “RoSPA wants every employee, wherever they are, to work safe in the knowledge that they will be going home unharmed and healthy at the end of every day. The RoSPA Award winners are vital to help achieve this goal, as by entering they are driving up standards and setting new benchmarks for organizations everywhere. Currently, around 7 million people are directly impacted by the RoSPA Awards, but the scheme’s influence is even wider.”

“We are pleased to receive this prestigious award for the second year running, underlining Catalent’s commitment to excellence in its Environment, Health and Safety Management System and the safety of our staff,” added Pete Williams, Vice-President, Global EHS, Security and Reliability Excellence at Catalent.

Catalent will be presented with the award during a ceremony on Tuesday, September 8, 2020, at the ExCel Exhibition Centre, London.

For more information about the RoSPA Awards visit www.rospa.com/awards.

Notes for Editors

ABOUT CATALENT CLINICAL SUPPLY SERVICES

Catalent is a global leader in clinical supply services, with comprehensive and flexible solutions for small molecules, biologics, and cell and gene therapies and integrated solutions to accelerate speed to clinic. Catalent offers a full range services including clinical supply management, comprehensive packaging solutions, comparator sourcing, cold chain storage and global distribution and specialized supply chain services including direct-to-patient and demand-led supply. With nine GMP clinical packaging facilities and over 50 strategically located depots on six continents combined with more than 25 years’ experience across thousands of studies in more than 80 countries, Catalent has the comprehensive services, global scale and expertise necessary to reliably supply clinical trials of all sizes and complexity anywhere in the world.

ABOUT CATALENT

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 13,000 people, including over 2,400 scientists and technicians, at more than 35 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com

 

More products. Better treatments. Reliably supplied.™